Search: onr:"swepub:oai:gup.ub.gu.se/264451" >
High expression of ...
High expression of MKP1/DUSP1 counteracts glioma stem cell activity and mediates HDAC inhibitor response
-
Arrizabalaga, O. (author)
-
Moreno-Cugnon, L. (author)
-
Auzmendi-Iriarte, J. (author)
-
show more...
-
Aldaz, P. (author)
-
de Caceres,, II (author)
-
Garros-Regulez, L. (author)
-
Moncho-Amor, V. (author)
-
Torres-Bayona, S. (author)
-
Pernia, O. (author)
-
Pintado-Berninches, L. (author)
-
Carrasco-Ramirez, P. (author)
-
Cortes-Sempere, M. (author)
-
Rosas, R. (author)
-
Sanchez-Gomez, P. (author)
-
Ruiz, I. (author)
-
- Carén, Helena, 1979 (author)
- Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för patologi,Sahlgrenska Cancer Center,Institute of Biomedicine, Department of Pathology
-
Pollard, S. (author)
-
Garcia, I. (author)
-
Sacido, A. A. (author)
-
Lovell-Badge, R. (author)
-
Belda-Iniesta, C. (author)
-
Sampron, N. (author)
-
Perona, R. (author)
-
Matheu, A. (author)
-
show less...
-
(creator_code:org_t)
- 2017-12-14
- 2017
- English.
-
In: Oncogenesis. - : Springer Science and Business Media LLC. - 2157-9024. ; 6
- Related links:
-
https://www.nature.c...
-
show more...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- The elucidation of mechanisms involved in resistance to therapies is essential to improve the survival of patients with malignant gliomas. A major feature possessed by glioma cells that may aid their ability to survive therapy and reconstitute tumors is the capacity for self-renewal. We show here that glioma stem cells (GSCs) express low levels of MKP1, a dual-specificity phosphatase, which acts as a negative inhibitor of JNK, ERK1/2, and p38 MAPK, while induction of high levels of MKP1 expression are associated with differentiation of GSC. Notably, we find that high levels of MKP1 correlate with a subset of glioblastoma patients with better prognosis and overall increased survival. Gain of expression studies demonstrated that elevated MKP1 impairs self-renewal and induces differentiation of GSCs while reducing tumorigenesis in vivo. Moreover, we identified that MKP1 is epigenetically regulated and that it mediates the anti-tumor activity of histone deacetylase inhibitors (HDACIs) alone or in combination with temozolomide. In summary, this study identifies MKP1 as a key modulator of the interplay between GSC self-renewal and differentiation and provides evidence that the activation of MKP1, through epigenetic regulation, might be a novel therapeutic strategy to overcome therapy resistance in glioblastoma.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Keyword
- protein-kinase phosphatase-1
- tumor-initiating cells
- human
- breast-cancer
- n-terminal kinase
- p38 mapk
- temozolomide resistance
- human glioblastoma
- pivotal role
- lung-cancer
- activation
- Oncology
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database
- By the author/editor
-
Arrizabalaga, O.
-
Moreno-Cugnon, L ...
-
Auzmendi-Iriarte ...
-
Aldaz, P.
-
de Caceres,, II
-
Garros-Regulez, ...
-
show more...
-
Moncho-Amor, V.
-
Torres-Bayona, S ...
-
Pernia, O.
-
Pintado-Berninch ...
-
Carrasco-Ramirez ...
-
Cortes-Sempere, ...
-
Rosas, R.
-
Sanchez-Gomez, P ...
-
Ruiz, I.
-
Carén, Helena, 1 ...
-
Pollard, S.
-
Garcia, I.
-
Sacido, A. A.
-
Lovell-Badge, R.
-
Belda-Iniesta, C ...
-
Sampron, N.
-
Perona, R.
-
Matheu, A.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cancer and Oncol ...
- Articles in the publication
-
Oncogenesis
- By the university
-
University of Gothenburg